Search
for
Sort by
Research 211–240 of 1000+
- Improving selective androgen receptor modulator discovery and preclinical evaluation
- Drug Repurposing against KRAS Mutant G12C: A Machine Learning, Molecular Docking, and Molecular Dynamics Study
- Synthesis of 17β-N-arylcarbamoylandrost-4-en-3-one derivatives and their anti-proliferative effect on human androgen-sensitive LNCaP cell line
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- The Role of Histone Demethylases in Disease
- Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets
- Pharmacophore Modeling and Three Dimensional Database Searching for Drug Design Using Catalyst: Recent Advances
- Potential Medical Uses of Cannabigerol: A Brief Overview
- PŁYNY- NIE ZA DUŻO, NIE ZA MAŁO, LECZ W SAM RAZ
- Hormesis and medicine
- Treatment options for alopecia: an update, looking to the future
- Traditional uses, phytochemistry, pharmacology, toxicity and clinical application of traditional Chinese medicine Cynoglossum amabile: a review
- Design, synthesis and anti-tumor evaluation of novel thiohydantoin congeners as androgen receptor antagonists with in vivo study.
- The prevention of benign prostatic hyperplasia (bph)
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Androgen Receptor Actions Modify Skin Structure and Chemical Carcinogen-induced Skin Cancer Susceptibility in Mice
- Synthesis and application of clinically approved small-molecule drugs targeting androgen receptor
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- Natural bioactive compounds as potential sources for alleviation and treatment of androgenetic alopecia: A research advance
- Bicalutamide: A review
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Noncalcemic actions of 1,25-dihydroxyvitamin D3 and clinical applications
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Evolution, classification, structure, and functional diversification of steroid 5α-reductase family in eukaryotes
- Novel Synthetic Steroid Derivatives: Target Prediction and Biological Evaluation of Antiandrogenic Activity
- Translating Resveratrol Research: A Systematic Review on Patents and Clinical Trials (2000–2025)
- Therapeutic Potential of Brassinosteroids in Biomedical and Clinical Research
- Targeting the Warburg Effect in Anaplastic Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic Opportunities
- Forum
- The Multiple Consequences of Obesity